ExoVerita™ Pro System
ExoVerita Pro standardizes and simplifies exosome isolation workflows while generating high purity and yield to convert samples into meaningful insights for research. The platform isolates exosomes from a variety of biofluids including whole blood, plasma, serum cerebrospinal fluid and more. Our integrated cartridge performs all isolation processes automatically. Exosome isolation can be performed in three simple steps — just add sample and reagent to the cartridge; load into the instrument; and walk away.
VERITA MEANS TRUTH
ExoVerita™ Pro Platform
The revolutionary technology driving our science, enabling rapid and easy exosome isolation, providing superior performance of our instruments and your discoveries.
EXOSOMES TELL THE STORY.
Advancing oncology. Revealing new pathways for research. Providing more relevant data for each patient. And playing the key role in earlier detection of disease. Join us in unlocking the power of exosomes and applying the groundbreaking benefits that result from their study.
ABOUT US
Biological Dynamics, Inc. is a leader in exosome-isolation technology. We are committed to improving global health outcomes by enabling tests that better detect a range of conditions, including early stage cancer, treatment response, and cancer recurrence. Using exosomes, these test can provide higher sensitivity than competing approaches. Our ExoVerita™ Pro platform revolutionizes exosomes and extracellular vesicle isolation by enabling a simple, reliable, and automated workflow to enrich for exosomes, powering scalable clinical tests for us and our customers to address some of the most challenging diseases.
CAREERS
Our talented staff thrive in an open environment where curiosity, innovation and vision are vital parts of the equation. With an inclusive and inspiring culture, we offer a terrific opportunity to discover, learn and grow.
If you are ready to join a dynamic team where you can contribute to the next exciting breakthrough in early disease detection, we are the company for you.
In the dynamic field of cancer research, the hunt for breakthroughs in early disease detection is critical for improving patient outcomes. Exosomes are garnering attention for their potential in cancer diagnostics. The emergence of exosomes and their cargo as important biomarkers in disease monitoring, early discovery, and precision medicine may herald a transformative era in patient care.